Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02466009
Title Regorafenib in Metastatic Colorectal Cancer
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors University of Rochester
Indications
Therapies
Age Groups: senior
Covered Countries USA

Facility Status City State Zip Country Details
Mayo Clinic Rochester Minnesota 55901 United States Details
University of Rochester Rochester New York 14642 United States Details
University of North Carolina at Chapel Hill Chapel Hill North Carolina 27514 United States Details
Fox Chase Cancer Center Philadelphia Pennsylvania 19111 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field